Evidence map›Paper›PMID 39223388›Full record

ArticleNature chemical biology2025

An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation.

Brandon Novy, Aleksandra Dagunts, Tatum Weishaar, Emily E Holland, Hayden Adoff, Emily Hutchinson, Monica De Maria, Martin Kampmann, Nikoleta G Tsvetanova, Braden T Lobingier

Abstract read
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Structural Mechanisms of DNAJC13 Dimeric Assembly and InsPbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. A genome-wide CRISPR screen defines host determinants of earlybioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Illuminating GPCR trafficking.Nature chemical biology · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brandon NovyDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0001-5304-2640
Aleksandra DaguntsDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0001-9378-8017
Tatum WeishaarDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
Emily E HollandDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
Hayden AdoffDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0002-0373-3678
Emily HutchinsonDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
Monica De MariaDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
Martin KampmannDepartment of Biochemistry and Biophysics and Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3819-7019
Nikoleta G TsvetanovaDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.ORCID 0000-0001-6533-187X
Braden T LobingierDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA. lobingib@ohsu.edu.ORCID 0000-0001-7881-7502

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
PROTEINS REGULATING ENDOCYTOSIS OF OPIOID RECEPTORSR01DA012864 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark E Von Zastrow · 2000 to 2026
$7.9M
Membrane Trafficking of Opioid and Adrenergic ReceptorsR01DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2014 to 2023
$4.6M
Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomicsR01AG062359 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMPMANN, MARTIN · 2018 to 2022
$3.2M
Program in Biomedical SciencesT32GM142619 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeffrey Wallace Tyner · 2021 to 2026
$3.2M
MEMBRANE TRAFFICKING OF OPIOID RECEPTORSR37DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2004 to 2013
$3.1M
Endosomes as a multifunctional hub to control GPCR functionR35GM137835 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Braden Lobingier · 2020 to 2026
$2.5M
Characterization of Compartmentalized GPCR Signaling in NeuronsR01NS127847 · NINDS · DUKE UNIVERSITY · PI Nikoleta Georgieva Tsvetanova · 2022 to 2026
$1.9M
Molecular and Cellular Biophysics Training GrantT32GM148376 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew R Redinbo, Qi Zhang · 2024 to 2026
$1.4M
Chemical Physiology Training ProgramT32GM142625 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BETH A HABECKER · 2022 to 2026
$938k
NCI NIH HHS P30 CA069533NCI NIH HHS P30 CA082103NEI NIH HHS P30 EY010572NIA NIH HHS R01 AG062359NIDA NIH HHS K99 DA043607NIDA NIH HHS R00 DA043607NIDA NIH HHS R01 DA010711NIDA NIH HHS R01 DA012864NIDA NIH HHS R29 DA010711NIDA NIH HHS R37 DA010711NIGMS NIH HHS R35 GM137835NIGMS NIH HHS T32 GM142619NIGMS NIH HHS T32 GM142625NIGMS NIH HHS T32 GM148376NIH HHS S10 OD012246NINDS NIH HHS R01 NS127847U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM137835U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS127847U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG062359U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA043607
6 · The paper itself

Abstract

Trafficking of G protein-coupled receptors (GPCRs) through the endosomal-lysosomal pathway is critical to homeostatic regulation of GPCRs following activation with agonist. Identifying the genes involved in GPCR trafficking is challenging due to the complexity of sorting operations and the large number of cellular proteins involved in the process. Here, we developed a high-sensitivity biosensor for GPCR expression and agonist-induced trafficking to the lysosome by leveraging the ability of the engineered peroxidase APEX2 to activate the fluorogenic substrate Amplex UltraRed (AUR). We used the GPCR-APEX2/AUR assay to perform a genome-wide CRISPR interference screen focused on identifying genes regulating expression and trafficking of the δ-opioid receptor (DOR). We identified 492 genes consisting of both known and new regulators of DOR function. We demonstrate that one new regulator, DNAJC13, controls trafficking of multiple GPCRs, including DOR, through the endosomal-lysosomal pathway by regulating the composition of the endosomal proteome and endosomal homeostasis.

Indexed as

Biosensing TechniquesDown-RegulationHSP40 Heat-Shock ProteinsReceptors, Opioid, deltaEndosomesHEK293 CellsHumansLysosomesProtein TransportHSP40 Heat-Shock ProteinsReceptors, Opioid, delta

Identifiers

PMID39223388
PMCPMC11867885

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.